A Importância do Monitoramento e da Identificação Precoce de Cardiotoxicidade do Tratamento com Trastuzumabe no Câncer de Mama: Relato de Caso

Valente, Patricia Marques Soares; Souza, Walter Claudino Pires de; Braga, Eduardo Pinho; Neves, Thamires Ferreira; Silva, Thamires Lopes da; Martins, Wolney de Andrade; Castilho, Selma Rodrigues de.
Rev. bras. cancerol ; 65(3)19/09/2019.
Artigo em Português | LILACS | ID: biblio-1047725

Similares

  1. Deceleration capacity of heart rate predicts trastuzumab-related cardiotoxicity in patients with HER2-positive breast cancer: A prospective observational study.
  2. Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways.
  3. Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?
  4. Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report.
  5. Heart failure related to contemporary breast cancer treatment.
  6. Cardiac toxicity of patients on short course trastuzumab in combination with chemotherapy (FinHer Protocol) in breast cancer.
  7. Replication Study for the Association of Five SNPs Identified by GWAS and Trastuzumab-Induced Cardiotoxicity in Japanese and Singaporean Cohorts.
  8. Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer.
  9. ACEI/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breast cancer: a systematic review and meta-analysis.
  10. Prognostic value of left ventricular global longitudinal strain on speckle echocardiography for predicting chemotherapy-induced cardiotoxicity in breast cancer patients: A systematic review and meta-analysis.